2021 | Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan | YU-YUN SHAO ; Wang, Shen-Yung; Lin, Shi-Ming; Chen, Kuan-Yang; Tseng, Jeng-Hwei; MING-CHIH HO ; Lee, Rheun-Chuan; PO-CHIN LIANG ; Liao, Li-Ying; KAI-WEN HUANG ; Hu, Jui-Ting; JA-DER LIANG ; Kee, Kwong-Ming; Lin, Chih-Lin; Wang, Chung-Kwe; Lu, Sheng-Nan; Wang, Jing-Houng; Lee, Wei-Chen; CHIEN-HUNG CHEN ; CHUN-JEN LIU ; Huang, Yi-Hsiang; Wang, Chia-Chi; Wang, Tsang-En; Chuang, Po-Heng; Dai, Chia-Yen; CHIUN HSU ; Chen, San-Chi; Hsieh, Chia-Hsun | Journal of the Formosan Medical Association | 64 | 65 | |
2023 | Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatment | Chang, Pi-Yi; Lee, Rheun-Chuan; PO-CHIN LIANG ; Liu, Yi-Sheng; Chuang, Vicent P; Wu, Ding-Kwo; Cheng, Yu-Fan; Huang, Jen-I; Tseng, Hsiuo-Shan; Hung, Chien-Fu; Wu, Reng-Hong; Chern, Ming-Chih; Cheng, Hua-Ming; CHIH-HORNG WU ; Cheng, She-Meng; Chiang, Chia-Ling; Liang, Huei-Lung | Frontiers in oncology | 0 | 0 | |